Abstract Details

Title Progression of Whole Brain and Gray Matter Atrophy in Relapsing MS Despite Treatment with Natalizumab

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 357

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Adil Javed, MD, PhD (University of Chicago) PRESENTER	No disclosure on file
Nancy Arndt, NP (University of Chicago)	No disclosure on file
Anthony Reder, MD (University of Chicago)	The institution of Dr. Reder has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for genentech. Dr. Reder has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen . Dr. Reder has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for serono. Dr. Reder has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NK max. Dr. Reder has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. Dr. Reder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for medlink. The institution of Dr. Reder has received research support from genentech. The institution of Dr. Reder has received research support from biogen. The institution of Dr. Reder has received research support from serono. The institution of Dr. Reder has received research support from novartis.